Screener
OrthoPediatrics KIDS EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by OrthoPediatrics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: OrthoPediatrics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 1:56 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001425450-26-000070
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other expense (income), net | 2,861 | (3,593) | 5,385 | (4,111) |
| Net loss before income taxes | $(6,929) | $(7,064) | $(17,787) | $(17,527) |
| Income tax charge | 234 | 49 | 63 | 245 |
| Net loss | $(7,163) | $(7,113) | $(17,850) | $(17,772) |
| Weighted average shares outstanding | ||||
| Basic and diluted | 24,048,690 | 23,460,144 | 23,867,877 | 23,346,141 |
| Net loss per share | ||||
| Basic and diluted | $(0.30) | $(0.30) | $(0.75) | $(0.76) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is OrthoPediatrics's EPS (diluted)?
- OrthoPediatrics (KIDS) reported EPS (diluted) of -$0.30 in Q2 2026.
- How has OrthoPediatrics's EPS (diluted) changed year-over-year?
- OrthoPediatrics's EPS (diluted) decreased by 0.0% year-over-year, from -$0.30 to -$0.30.
- What is the long-term trend for OrthoPediatrics's EPS (diluted)?
- Over 3 years (2021 to 2025), OrthoPediatrics's EPS (diluted) has grown at a 26.2% compound annual growth rate (CAGR), from -$0.84 to -$1.69.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about OrthoPediatrics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude